So I'm not quite sure how this new 140 patient trial is going to work. If we are trying to prove that we save lives in critical patients, we have to have a placebo arm, why I'm not quite sure when the FDA has access to SOC on 24 million patients. But this puts us into a real catch 22 position. We have to stop eIND and who would want to put their patient into a trial with the possibility of getting the placebo.

Why can't we just get an EUA for critical and see how well we do with 140 patients? I mean didn't the FDA do that with the vaccines, didn't they continue trials while give the drug out? Can't our management push for that?